|国家科技期刊平台
首页|期刊导航|中国实用外科杂志|肝癌肝切除质量控制体系的建立及评价

肝癌肝切除质量控制体系的建立及评价OA北大核心CSTPCD

Establishment and evaluation of quality control system for hepatectomy in hepatocellular carcinoma

中文摘要英文摘要

以手术为主的综合治疗是目前肝癌治疗的主要模式,由于肝脏结构的特殊性,肝癌肝切除具有高技术含量和高风险性的特征,既要保证围手术期安全和加速康复,又要争取肿瘤学获益,同时肝癌肝切除也面临技术推广普及和同质化管理的瓶颈,迫切需要建立中国特色的肝癌肝切除的质量控制管理系统.肝癌肝切除的过程质量控制包括术前评估、手术方式及关键技术、术后监测及康复.结果质量控制包括围手术期死亡率、并发症发生率、平均住院日、非计划再次手术率等.规范细致的过程质量控制将会带来良好的临床结局.肝癌肝切除质量控制指标的凝练将随着精准微创技术的发展而不断完善.

Surgery-based comprehensive treatment is the primary mode of therapy for liver cancer at present.Due to the unique structure of the liver,hepatic resection for liver cancer is characterized by high technical complexity and risk.Given the unique complexity and inherent risks associated with liver cancer resection,it is crucial to ensure both perioperative safety and expedited recovery,all while aiming for optimal oncological outcomes.However,the challenges lie in the widespread adoption and standardized management of this intricate procedure,highlighting the pressing need to establish a specialized quality control management system for liver cancer resection in China.The process control of liver cancer resection includes preoperative assessment,surgical procedures and key techniques,postoperative monitoring,and rehabilitation.Outcome control includes perioperative mortality,complication rates,average length of hospital stay,unplanned reoperation rates,among others.Standardized and detailed process control is expected to yield favorable clinical outcomes.The refinement of quality control indicators for liver cancer hepatic resection will continue to improve with the development of precision minimally invasive techniques.

陈亚进

中山大学孙逸仙纪念医院肝胆外科,广东广州 510120

临床医学

肝癌肝切除质量控制

liver cancerliver resectionquality control

《中国实用外科杂志》 2024 (001)

TNF-α促进肿瘤相关成纤维细胞分泌HGF调控c-Met/circ-CCNY信号通路介导肝癌进展的机制研究

52-54 / 3

国家自然科学基金项目(No.81972263)

10.19538/j.cjps.issn1005-2208.2024.01.07

评论